[b]Depression Market Share, Size, Syndrome, Pipeline Review, H2 2015[/b]

[b]Summary[/b]

Global Markets Direct's, 'Depression - Pipeline Review, H2 2015', provides an overview of the Depression's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Depression and special features on late-stage and discontinued projects.

[b]Access Full Report With TOC @ [color=#ff0000]http://www.radiantinsights.com/research/depression-pipeline-review-h2-2015[/color][/b]

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

[b]Note*:[/b] Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

[b]Scope[/b]

- The report provides a snapshot of the global therapeutic landscape of Depression
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Depression and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Depression products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Depression pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

[b]Browse Upcoming Reports @ [color=#ff0000]http://www.radiantinsights.com/upcoming-reports[/color][/b]

[b]About Us:[/b]

Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

[b]Contact Details:[/b]

Michelle Thoras
Corporate Sales Specialist, USA

Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: [color=#ff0000]http://www.radiantinsights.com/[/color]
Email: [email protected]